Walkersville, MD, United States of America

John H Cardellina, Ii


Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1994-2004

Loading Chart...
12 patents (USPTO):Explore Patents

Title: John H Cardellina II: Innovator in Antiviral Compounds

Introduction

John H Cardellina II is a notable inventor based in Walkersville, MD (US). He has made significant contributions to the field of antiviral compounds, holding a total of 12 patents. His work focuses on developing novel compounds that can combat viral infections, particularly those caused by retroviruses.

Latest Patents

One of Cardellina's latest patents is titled "Calanolide and related antiviral compounds, compositions, and uses thereof." This invention provides novel antiviral compounds known as calanolides, which can be isolated from plants of the genus Calophyllum. These compounds and their derivatives may be utilized alone or in combination with other antiviral agents in pharmaceutical compositions. The primary aim is to inhibit the growth or replication of viruses, specifically targeting human immunodeficiency viruses, HIV-1 and HIV-2.

Career Highlights

Throughout his career, Cardellina has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His research has been pivotal in advancing antiviral therapies and improving public health outcomes.

Collaborations

Cardellina has collaborated with notable professionals in his field, including Michael R Boyd and James Brislin McMahon. These partnerships have contributed to the success of his research and the development of innovative antiviral solutions.

Conclusion

John H Cardellina II stands out as a significant figure in the realm of antiviral research. His inventions and collaborations have the potential to make a lasting impact on the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…